Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
BMJ Open|November 28, 2020
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-registerGualtiero Palareti, Emilia Antonucci, Cristina Legnani, et al.
British Journal of Haematology|May 20, 2003
Asymptomatic carriership of factor V Leiden and genotypes of the fibrinogen gene clusterGiovanna Marchetti, Paolo Ferraresi, Cristina Legnani, et al.
Therapeutic Advances in Drug Safety|January 6, 2022
Do women with venous thromboembolism bleed more than men during anticoagulation? Data from the real-life, prospective START-RegisterGualtiero Palareti, Cristina Legnani, Emilia Antonucci, et al.
Thrombosis and Haemostasis|June 1, 2023
Venous Thromboembolism in Women of Childbearing Age: Insights from the START RegistryElvira Grandone, Emilia Antonucci, Donatella Colaizzo, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 28, 2010
Effects of unfractioned heparin and low-molecular-weight heparin on osteoprotegerin and RANKL plasma levels in haemodialysis patientsGiuseppe Cianciolo, Gaetano La Manna, Gabriele Donati, et al.
The European Respiratory Journal|February 27, 2016
Duration of anticoagulation after isolated pulmonary embolismGualtiero Palareti, Benilde Cosmi, Emilia Antonucci, et al.
Blood|December 8, 2009
Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective studyBenilde Cosmi, Cristina Legnani, Alberto Tosetto, et al.
Thrombosis Research|November 3, 2009
Membrane binding and anticoagulant properties of protein S natural variantsMarcello Baroni, Giulia Pavani, Diego Marescotti, et al.
Blood|August 6, 2013
Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphismsPaolo Bucciarelli, Valerio De Stefano, Serena M Passamonti, et al.
International Journal of Laboratory Hematology|February 11, 2020
DOAC plasma levels measured by chromogenic anti-Xa assays and HPLC-UV in apixaban- and rivaroxaban-treated patients from the START-RegisterMichela Cini, Cristina Legnani, Roberto Padrini, et al.
Pageof 10